- Home
- FOCL vs ALEC Comparison
FOCL vs ALEC Comparison
Compare FOCL & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FOCL | ALEC |
|---|---|---|
| Founded | N/A | 2013 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.7M | 167.6M |
| IPO Year | 1998 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FOCL | ALEC |
|---|---|---|
| Price | $4.20 | $2.56 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.83 |
| AVG Volume (30 Days) | 199.0K | ★ 1.4M |
| Earning Date | N/A | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $70,527,000.00 | $21,045,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | N/A | $29.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.63 | N/A |
| 52 Week Low | $4.01 | $1.09 |
| 52 Week High | $6.40 | $3.40 |
Technical Indicators
Market Signals| Indicator | FOCL | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 61.46 |
| Support Level | $4.01 | $1.93 |
| Resistance Level | $4.50 | $2.58 |
| Average True Range (ATR) | 0.19 | 0.22 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 58.16 | 65.29 |
Price Performance
Historical ComparisonAbout FOCL EDAP TMS S.A. American Depositary Shares
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.